Synthetic self‐adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy
Article in MedComm (February 2024)
The most recent citing publications are shown below. View all 80 publications that cite this research output on Dimensions.
Article in MedComm (February 2024)
Article in International Immunopharmacology (January 2024)
Article in Angewandte Chemie (January 2024)